DiscoverThe Cannabis Investing PodcastDe-risking psychedelics: Compass Pathways, Cybin and Atai
De-risking psychedelics: Compass Pathways, Cybin and Atai

De-risking psychedelics: Compass Pathways, Cybin and Atai

Update: 2024-01-09
Share

Description

Alex Carchidi updates us on the psychedelic sector and what critical catalysts are approaching (1:30 ). Why Compass Pathways, Cybin, and Atai make the most sense for investors at this point (15:00 ). Pros and cons of 4 main industry stocks, including MindMed (29:50 ).

Episode transcripts

Show Notes:
Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.
Psychedelic Stocks: Don't Bet On Just 1 Company
Psychedelic Sunday: Scrutinizing Psychedelic Stocks
Cybin: A Leading Early-Stage Psychedelics Play

For full access to analyst ratings, stock quant scores and dividend grades: seekingalpha.com/subscriptions

Cannabis Investing Podcast on Twitter
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

De-risking psychedelics: Compass Pathways, Cybin and Atai

De-risking psychedelics: Compass Pathways, Cybin and Atai

Seeking Alpha